Latest filing published 21 Mar 2016 for Elite Pharmaceuticals INC, €96k.
Insider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +42.9%Entry US$0.07 · Close at T+365 US$0.10
- +116.7%Entry US$0.06 · Close at T+365 US$0.13
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jerry Treppel: trading record in brief
Filings by Jerry Treppel span 2 companies, the busiest being Akorn Inc and Elite Pharmaceuticals Inc. The record holds 87 filings, for trades running from 13 January 2006 to 18 March 2016.
In open-market terms, that means 2 purchases worth €44k on one side and 64 sales worth €2.5M on the other. Sales outweigh purchases by €2.5M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 9 share grants and 2 option exercises. Since January 2016: no purchases and 11 sales on the market.
The record was last updated on 21 March 2016 with an open-market sale (€96k) in Elite Pharmaceuticals Inc. The last insider purchase was made public on 16 March 2011, 5,716 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jerry Treppel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 312,430 shares@ US$0.34518.0% of flowCommon StockSEC:0001213711-16-000003:0
- 258,090 shares@ US$0.34214.6% of flowCommon StockSEC:0001213711-16-000003:1
- 100,000 shares@ US$0.32095.4% of flowCommon StockSEC:0001213711-16-000001:0
- 100,456 shares@ US$0.315.3% of flowCommon StockSEC:0001213711-16-000001:1
- 115,000 shares@ US$0.356.9% of flowCommon StockSEC:0001053369-16-000042:0
- 312,300 shares@ US$0.3418.4% of flowCommon StockSEC:0001053369-16-000042:1
- 13,000 shares@ US$0.330.7% of flowCommon StockSEC:0001053369-16-000042:2
- 124,646 shares@ US$0.24795.2% of flowCommon StockSEC:0001053369-16-000042:6
- 50,000 shares@ US$0.31162.6% of flowCommon StockSEC:0001053369-16-000042:7
- 45,518 shares@ US$0.332.6% of flowCommon StockSEC:0001053369-16-000042:3
- 349,660 shares@ US$0.3218.9% of flowCommon StockSEC:0001053369-16-000042:4
- 24,400 shares@ US$0.331.3% of flowCommon StockSEC:0001053369-16-000042:5
- 50,000 shares@ US$0.30Common StockSEC:0001053369-15-000034:1
- 50,000 shares@ US$0.3025Common StockSEC:0001053369-15-000034:2
- 25,000 shares@ US$0.3001Common StockSEC:0001053369-15-000034:3
- 25,000 shares@ US$0.305Common StockSEC:0001053369-15-000034:4
- 7,500 shares@ US$0.31Common StockSEC:0001053369-15-000034:0
- 87,711 shares@ US$0.342common stockSEC:0001053369-15-000003:0
- 6,060,000 shares0Common StockSEC:0001213711-14-000005:0
- 375,000 shares@ US$0.125Common StockSEC:0001053369-14-000031:0
- 375,000 shares@ US$0.25Common StockSEC:0001465826-14-000005:0
- 180,000 shares@ US$0.06Common StockSEC:0001213711-14-000003:0
- 4.24 shares@ US$141,442.72Series I Convertible Preferred SharesSEC:0001053369-14-000016:0
- 277,058 shares@ US$0.08Common StockSEC:0001053369-13-000014:0
- 3,200 shares@ US$0.142Common StockSEC:0001345568-12-000027:0
25 of 84 declarations